Zurich, October 15, 2024 – A groundbreaking stereo microscope system developed by ETH Zurich and Leica Microsystems is set to redefine surgical precision. Dubbed NeoVision, this intelligent imaging platform combines advanced optics with real-time artificial intelligence to assist surgeons during complex procedures.

The system's standout features include:

: Proprietary AI algorithms instantly identify critical anatomical structures like blood vessels and nerves, reducing operative risks by 38% in clinical trials

: Projects 3D patient scans directly into the surgeon's visual field, effectively creating "X-ray vision" during operations

: Seamlessly switches between macro-scale visualization (5-20X) for surgical navigation and high-magnification detail (40-160X) for microsuturing

At Geneva University Hospital, neurosurgeons successfully removed five complex brain tumors using NeoVision. The system's haptic feedback mechanism warned surgeons when instruments approached sensitive neural tissue, while its cloud-based consultation feature allowed real-time collaboration with specialists worldwide.

Beyond medicine, Leica has adapted the technology for industrial quality control. An automotive version will debut in 2025 for inspecting electric vehicle battery micro-welds, where its sub-micron resolution can detect defects invisible to conventional systems.

"NeoVision represents a paradigm shift," explains lead developer Prof. Marco Conti. "It doesn't replace surgical skill – it augments human capabilities with computational precision." The system maintains strict human oversight, with all AI recommendations requiring surgeon confirmation to meet EU medical device regulations.

With FDA fast-track review underway, medical commercialization is expected in early 2025. Analysts project the technology could reduce average neurosurgery duration by 25%, potentially saving hospitals millions annually in operational costs.

The development team emphasizes that all AI decisions are logged and auditable, addressing concerns about algorithmic transparency in life-critical applications.

Researchers will demonstrate NeoVision's capabilities at IEEE EMBC 2025 in Berlin, including live simulations of its augmented reality guidance system.